Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytokinetics Incorporated logo

Director Parshall B Lynne sold $306,050 worth of shares (5,000 units at $61.21), decreasing direct ownership by 22% to 17,933 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CYTK· Cytokinetics Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTK (Cytokinetics Incorporated) and more on Quantisnow.